Skip to main content Skip to section navigation Skip to footer
TCBiopharm.com

TC BioPharm Limited

  • Investors
  • Overview
  • News
    • Overview
    • Press Releases
    • Media Coverage
    • Email Alerts
  • Events & Presentations
    • Overview
    • Events
    • Presentations
  • Company Info
    • Overview
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • General Meeting
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

Press Releases

News

News

  • Overview
  • Press Releases
  • Media Coverage
  • Email Alerts
      Jan 17, 2023 8:30am EST

      TC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology

      Dec 12, 2022 9:00am EST

      TC BioPharm Reports First Half 2022 Financial Results and Provides Shareholder Update

      Nov 30, 2022 6:43pm EST

      TC BioPharm Announces Closing of $7.35 Million Private Placement

      Nov 28, 2022 8:00am EST

      TC BioPharm Announces $7.35 Million Private Placement

      Nov 22, 2022 8:00am EST

      TC BioPharm Begins Dosing Phase 2B Clinical Study Evaluating its Lead Compound, OmnImmune®, in Patients with Acute Myeloid Leukemia

      Oct 26, 2022 8:30am EDT

      TC BioPharm Announces Key Additions to Scientific Advisory Board, Expanding Cell Therapy Expertise

      Oct 03, 2022 8:30am EDT

      TC BioPharm to Present at Upcoming Investor Conferences

      Sep 13, 2022 9:30am EDT

      TC BioPharm Receives MHRA Approval for 18-Month Extrapolated Shelf-Life of Allogeneic Cell Therapy Product, OmnImmune®

      Aug 22, 2022 8:30am EDT

      TC BioPharm to Present at the H.C. Wainwright 24th Annual Global Investment Conference

      Jul 25, 2022 8:30am EDT

      TC BioPharm Executives to Speak at The 3rd Gamma Delta T Therapies Summit

      • arrow_back
      • 1…
      • 3
      • 4
      • 5
      • 6
      • 7
      • 8
      • 9
      • 10
      • 11
      • 12
      • arrow_forward
      rss_feed News RSS
      • Email Alerts
      • Contacts
      • RSS News Feed
      • Visit us on Facebook
      • Visit us on Twitter
      • Visit us on LinkedIn
      ©2025 TC BioPharm Limited. All Rights Reserved.
      Privacy Policy Disclaimer Sitemap

      This website stores cookies on your computer. These cookies, which also could include third party cookies, are used (among other purposes) to improve the website and provide more personalized services to you. To find out more about how we use cookies and how to change your settings, see our Privacy Policy.

      I Accept